{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/65736d39d32e730012c98919/67af7ba706ec54e1d24d3170?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Recursion Clinical Trial, CRISPR Delivery methods, preclinical Cas12 use, Gene Editing in AgBio, Top 10 Takeover Targets","description":"<p><strong>Season 2 Episode 1 (February 14, 2025): </strong>This week, the <em>GEN </em>editors discussed some interesting and developing stories around AI, including an in depth dialogue about what Recursion has been doing lately. They also discussed gene editing updates in delivery systems, Cas12 preclinical work, and AgBio. The discussion was rounded out with a look forward into takeover targets for 2025.&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>Featuring Alex Philippidis (Senior Business Editor, <em>GEN</em>), Fay Lin, PhD, (Editor, <em>GEN Biotechnology</em>), Uduak Thomas (Senior Editor, <em>GEN</em>), and moderated by Corinna Singleman, PhD, (Managing Editor, <em>GEN</em> and <em>IPM</em>)</p><p>&nbsp;</p><p>&nbsp;</p><p>Listed below are key references to the <em>GEN</em> stories, media, and other items discussed in this episode of <em>Touching Base</em>:</p><p>&nbsp;</p><p><a href=\"https://www.genengnews.com/topics/artificial-intelligence/as-pipeline-advances-recursion-expands-ai-focus-to-clinical-trials/\" rel=\"noopener noreferrer\" target=\"_blank\">As Pipeline Advances, Recursion Expands AI Focus to Clinical Trials</a></p><p>By Alex Phillipidis, <em>GEN</em>, Jan 30, 2025.</p><p>&nbsp;</p><p><a href=\"https://www.genengnews.com/topics/artificial-intelligence/recursion-announces-promising-clinical-data-on-lead-ai-based-drug-candidate-for-brain-disease/\" rel=\"noopener noreferrer\" target=\"_blank\">Recursion Announces Promising Clinical Data on Lead AI-Based Drug Candidate for Brain Disease</a></p><p>By Fay Lin, PhD, <em>GEN Edge</em>, Feb 5, 2025.</p><p>&nbsp;</p><p><a href=\"https://www.genengnews.com/topics/genome-editing/aav-delivered-nanocas-crispr-system-edits-muscle-in-non-human-primates/\" rel=\"noopener noreferrer\" target=\"_blank\">AAV Delivered NanoCas CRISPR System Edits Muscle in Non-Human Primates</a></p><p>By <em>GEN</em>, Feb 3, 2025.</p><p>&nbsp;</p><p><a href=\"https://www.genengnews.com/topics/genome-editing/next-gen-cas12a-system-enables-precise-single-and-multiplexed-gene-editing-in-cancer/\" rel=\"noopener noreferrer\" target=\"_blank\">Next-Gen Cas12a System Enables Precise Single and Multiplexed Gene Editing in Cancer</a></p><p>By Corinna Singleman, PhD, <em>GEN</em>, Jan 30, 2025.</p><p>&nbsp;</p><p><a href=\"https://www.genengnews.com/topics/genome-editing/agbio-companies-embrace-gene-editing-for-stronger-food-future/\" rel=\"noopener noreferrer\" target=\"_blank\">AgBio Companies Embrace Gene Editing for Stronger Food Future</a></p><p>By Uduak Thomas, <em>GEN</em> Feb issue, Feb 3, 2025.</p><p>&nbsp;</p><p><a href=\"https://www.genengnews.com/industry-news/top-10-takeover-targets-of-2025/\" rel=\"noopener noreferrer\" target=\"_blank\">Top 10 Takeover Targets of 2025</a></p><p>By Alex Phillippidis, <em>GEN,</em> Feb 3, 2025.</p><p><br></p><p><br></p>","author_name":"Genetic Engineering & Biotechnology News (GEN)"}